Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3392545 | Transplant Immunology | 2007 | 10 Pages |
Abstract
New immunosuppressive strategies have improved short- and long-term graft survival. The current aim is to decrease the intensity of the immunosuppressive regimen, in an attempt to limit side effects and the direct toxicity of calcineurin inhibitor (CNI) for kidney function. We describe here current experience in liver and liver–kidney transplantation, the mechanism of tolerance and the immunosuppressive strategy used in liver transplantation.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Severine Beaudreuil, Didier Samuel, Nathalie Rouas-Freiss, Antoine Durrbach,